Operating Income
Operating Income
Abbott Operating Income decreased by 40.2% to $1.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.6%, from $1.69B to $1.35B. Over 4 years (FY 2021 to FY 2025), Operating Income shows relatively stable performance with a -1.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
How to read this metric
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Detailed definition
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
Peer comparison
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
Metric ID:
operating_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.39B | $2.55B | $2.38B | $2.91B | $2.38B | $1.77B | $1.30B | $1.51B | $1.54B | $1.65B | $1.78B | $1.39B | $1.67B | $1.86B | $1.91B | $1.69B | $2.05B | $2.06B | $2.25B | $1.35B |
| QoQ Change | — | +82.9% | -6.6% | +22.5% | -18.4% | -25.5% | -26.3% | +15.7% | +2.2% | +6.8% | +8.1% | -22.1% | +20.4% | +11.4% | +2.8% | -11.4% | +21.2% | +0.2% | +9.4% | -40.2% |
| YoY Change | — | — | — | — | +70.7% | -30.5% | -45.2% | -48.2% | -35.1% | -6.9% | +36.5% | -8.2% | +8.2% | +12.9% | +7.4% | +22.2% | +22.9% | +10.7% | +17.8% | -20.6% |
Range$1.30B – $2.91B
CAGR-0.7%
Avg YoY Growth+0.9%
Median YoY Growth+7.8%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Devices | $1.51B | $1.51B | $1.77B | $1.61B | $1.80B | $1.83B | $1.98B | $1.89B |
| Established Pharmaceuticals | $315.00M | $380.00M | $271.00M | $298.00M | $346.00M | $391.00M | $255.00M | $365.00M |
| Diagnostic Products | $430.00M | $558.00M | $611.00M | $359.00M | $372.00M | $400.00M | $609.00M | $335.00M |
| Nutritional Products | $373.00M | $312.00M | $443.00M | $394.00M | $418.00M | $360.00M | $386.00M | $311.00M |
| Total | $1.67B | $1.86B | $1.91B | $1.69B | $2.05B | $2.06B | $2.25B | $1.35B |
Operating Income at Other Companies
Frequently Asked Questions
- What is Abbott's operating income?
- Abbott (ABT) reported operating income of $1.35B in Q1 2026.
- How has Abbott's operating income changed year-over-year?
- Abbott's operating income decreased by 20.6% year-over-year, from $1.69B to $1.35B.
- What is the long-term trend for Abbott's operating income?
- Over 4 years (2021 to 2025), Abbott's operating income has grown at a -1.1% compound annual growth rate (CAGR), from $8.43B to $8.05B.
- What does operating income mean?
- The profit a company makes from its core business operations before interest and taxes.